DOLORISK: Understanding Risk Factors and Determinants for Neuropathic Pain - Chronic Neuropathy Following Chemotherapy (DOLORisk)
DOLORisk is a multi-centre observational study that aims to understand the risk factors and determinants for neuropathic pain. Participant recruitment occurred between 2015 and 2019. The main longitudinal branch of the study consisted of 2 existing population cohorts: Generation Scotland (a family-based study) and GoDARTS (Genetics of Diabetes Audit and Research in Tayside Study—focused on diabetes), whose participants were contacted by the University of Dundee to be rephenotyped for neuropathic pain (approximately 9,000 respondents at baseline). Aarhus University and INSERM recruited smaller cohorts of participants scheduled to undergo chemotherapy, thoracic surgery, or breast cancer surgery.
Study design
Cohort - clinical
Number of participants at first data collection
No information found
Age at first data collection
≥ 18 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Countries
Year of first data collection
2016
Primary Institutions
Aarhus University Hospital (Aarhus Universitetshospital, AUH)
National Institute of Health and Medical Research (Institut National de la Santé et de la Recherche Médicale, INSERM)
Profile paper DOI
Funders
European Union Horizon 2020 Research and Innovation Program
International Diabetic Neuropathy Consortium (IDNC)
Novo Nordisk Foundation
Ongoing?
No
Data types collected
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- Self-report questionnaire – paper or computer assisted
- None
- Electroencephalography (EEG)
- None
Engagement
Keywords
